Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.
Researchers can test blood samples taken for other reasons to see if patients have previously had COVID-19.
Don Bartletti/Los Angeles Times via Getty Images
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
This device will provide results in a matter of minutes – while regular blood test results could take days or weeks.
goodbishop/ Shutterstock
Proposals in NSW to force someone who spits at or bites a frontline worker to be tested for HIV and other blood-borne viruses are a real problem - for workers and the public.
Cancerous tumours release DNA that can be found in the bloodstream.
Andrey_Popov/ Shutterstock
Expanding coronavirus testing is one of the most important tasks public health officials are tackling right now. But questions over accuracy of the two main types of tests have rightly caused concern.
The science is far from certain, but it appears at least a proportion of people who have had COVID-19 will be protected from another infection – at least initially.
Testing blood provides answers about who has been infected.
Sean Gallup/Getty Images News via Getty Images
After your body fights off an infection, antibodies remain in your blood. Two researchers explain how tests identify these antibodies and what the data can be used for.
Many cancer patients have chemotherapy after surgery, but not all of them actually need it.
from shutterstock.com
We have no reliable way of knowing which patients’ cancer will return after surgery, so often chemotherapy is given to mop up any remaining cancer cells that may have gone undetected.
Blood can tell us a lot about our health.
from www.shutterstock.com
By measuring a cancer cell’s DNA in the bloodstream, scientists can get a snapshot of the cancer itself, which is referred as a “liquid biopsy”.
Was Labor’s shadow health minister Catherine King, pictured here with shadow attorney-general Mark Dreyfus, right about cuts to bulk-billing payments?
Dan Himbrechts/AAP
Labor’s shadow health minister Catherine King, said that the government has “cut bulk-billing payments for pathology and diagnostic imaging to make patients pay more”. Is that right?
Pathology in Australia is big business.
ariadna de raadt/Shutterstock
Pathology Australia promptly abandoned its Don’t Kill Bulk Bill campaign against cuts to bulk-billing incentives after doing a deal with the federal government.
More than three in every four Medicare-billed pathology tests are analysed by one of two big corporations: Sonic Healthcare and Primary Health Care.
Soda_O2/Shutterstock
Industry consolidation and technological advances have completely reshaped the pathology industry over recent decades. But the way governments pay for pathology services hasn’t kept up.
Pregnant women in three Australian cities are not told that lead exposure during pregnancy is linked to miscarriage and early delivery.
Flickr/Luca Montanari
Parents in three Australian states are being given misleading advice about the dangers of lead to babies and small children – including failing to warn pregnant women about miscarriage risks.
A new study has suggested that it may be possible to develop blood tests for suicide by identifying biomarkers in the blood. Although it has its limitations, the study is an important step towards a more…
Associate Professor, Investigator for UNSW Digital Grid Futures Institute; Affiliated Investigator NHMRC Centre for Air Pollution, Energy and Health Research, Associate Investigator the ARC Centre of Excellence for Climate Extremes, UNSW Sydney